Proto Script Pharmaceutical (Proto Script Pharmaceutical) Net Change in Cash : $0.01 Mil (TTM As of Sep. 2017)

View and export this data going back to 2011. Start your Free Trial

What is Proto Script Pharmaceutical Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Proto Script Pharmaceutical's Net Change in Cash for the three months ended in Sep. 2017 was $0.00 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2017 was $0.01 Mil.

Proto Script Pharmaceutical Net Change in Cash Historical Data

The historical data trend for Proto Script Pharmaceutical's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proto Script Pharmaceutical Net Change in Cash Chart

Proto Script Pharmaceutical Annual Data

Trend

May12

May13

May14

May15

May16

Net Change in Cash

0.05

-0.03

-0.01

0.01

Proto Script Pharmaceutical Quarterly Data
	Nov12	Feb13	May13	Aug13	Nov13	Feb14	May14	Aug14	Nov14	Feb15	May15	Aug15	Nov15	Feb16	May16	Sep16	Dec16	Mar17	Jun17	Sep17
Net Change in Cash	Get a 7-Day Free Trial															-0.01	0.01	0.05	-0.06	-

Proto Script Pharmaceutical Net Change in Cash Calculation

Proto Script Pharmaceutical's Net Change in Cash for the fiscal year that ended in May. 2016 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-0.038	+	0	+	0.049	+	0
	=	0.01

Proto Script Pharmaceutical's Net Change in Cash for the quarter that ended in Sep. 2017

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.024 + -0.001 + 0.025 + 0

= 0.00

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Proto Script Pharmaceutical's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Proto Script Pharmaceutical Corp (OTCPK:PSCR) » Definitions » Net Change in Cash

Comparable Companies

WAR:ECA BOM:531259 WAR:EBC BOM:530787 EXCC BOM:540259 WAR:LGT NXES WAR:ASP WAR:CWA WAR:NFP WAR:UTD WAR:LPS PRZM WAR:ACA MIL:WMC WAR:ARI WAR:COM CVOVQ BOM:523712

Traded in Other Exchanges

N/A

Address

9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730

Website

http://www.psphomecare.com

Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.

Proto Script Pharmaceutical (Proto Script Pharmaceutical) Headlines

No Headlines